What is Immunome, Inc.'s Market Cap?

Immunome, Inc.'s Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Enterprise Value?

Immunome, Inc.'s Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s EV / EBITDA?

Immunome, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Revenue (TTM)?

Immunome, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Net Income (TTM)?

Immunome, Inc.'s Net Income (TTM) is -$254.3M, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s EBITDA?

Immunome, Inc.'s EBITDA is -$267.7M, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Diluted EPS (TTM)?

Immunome, Inc.'s Diluted EPS (TTM) is -2.24, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Net Debt?

Immunome, Inc.'s Net Debt is -$217.7M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Immunome, Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00BR94298

17.99▼ 0.27 (-1.48%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 18.26
Day's Range: 17.65 – 18.25
52-Week Range: 14.64 – 30.06
Volume: 1.4M
Avg Volume: 1.5M

Share Statistics

Shares Outstanding
Employees: 177
Exchange: XNAS
Listed: 2020-10-02

Share count as of August 6, 2026

Immunome, Inc. (IMNM) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Immunome, Inc. (IMNM)

What is Immunome, Inc.'s Market Cap?: Immunome, Inc.'s Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Enterprise Value?: Immunome, Inc.'s Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s EV / EBITDA?: Immunome, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Revenue (TTM)?: Immunome, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Net Income (TTM)?: Immunome, Inc.'s Net Income (TTM) is -$254.3M, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s EBITDA?: Immunome, Inc.'s EBITDA is -$267.7M, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Diluted EPS (TTM)?: Immunome, Inc.'s Diluted EPS (TTM) is -2.24, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Net Debt?: Immunome, Inc.'s Net Debt is -$217.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · IMNMAs-filed SEC (XBRL) data